Nanosphere Health Sciences Stock Net Income
| NSHSF Stock | USD 0.01 0.00 0.00% |
As of the 16th of February 2026, Nanosphere Health secures the Risk Adjusted Performance of 0.1007, standard deviation of 23.97, and Mean Deviation of 5.98. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nanosphere Health, as well as the relationship between them. Please verify Nanosphere Health risk adjusted performance, standard deviation, as well as the relationship between the Standard Deviation and maximum drawdown to decide if Nanosphere Health Sciences is priced some-what accurately, providing market reflects its recent price of 0.01 per share. As Nanosphere Health appears to be a penny stock we also strongly suggest to check its information ratio numbers.
Nanosphere Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Nanosphere Health's valuation are provided below:Nanosphere Health Sciences does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Nanosphere |
Nanosphere Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nanosphere Health's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nanosphere Health.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Nanosphere Health on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Nanosphere Health Sciences or generate 0.0% return on investment in Nanosphere Health over 90 days. Nanosphere Health is related to or competes with Mosaic Immunoengineerin. NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the... More
Nanosphere Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nanosphere Health's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nanosphere Health Sciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1099 | |||
| Maximum Drawdown | 216.93 |
Nanosphere Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nanosphere Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nanosphere Health's standard deviation. In reality, there are many statistical measures that can use Nanosphere Health historical prices to predict the future Nanosphere Health's volatility.| Risk Adjusted Performance | 0.1007 | |||
| Jensen Alpha | 2.7 | |||
| Total Risk Alpha | 0.9135 | |||
| Treynor Ratio | (20.98) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nanosphere Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nanosphere Health February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1007 | |||
| Market Risk Adjusted Performance | (20.97) | |||
| Mean Deviation | 5.98 | |||
| Coefficient Of Variation | 886.41 | |||
| Standard Deviation | 23.97 | |||
| Variance | 574.34 | |||
| Information Ratio | 0.1099 | |||
| Jensen Alpha | 2.7 | |||
| Total Risk Alpha | 0.9135 | |||
| Treynor Ratio | (20.98) | |||
| Maximum Drawdown | 216.93 | |||
| Skewness | 7.88 | |||
| Kurtosis | 63.51 |
Nanosphere Health Backtested Returns
Nanosphere Health is out of control given 3 months investment horizon. Nanosphere Health has Sharpe Ratio of 0.11, which conveys that the firm had a 0.11 % return per unit of risk over the last 3 months. We are able to interpolate and collect sixteen different technical indicators, which can help you to evaluate if expected returns of 2.79% are justified by taking the suggested risk. Use Nanosphere Health Mean Deviation of 5.98, standard deviation of 23.97, and Risk Adjusted Performance of 0.1007 to evaluate company specific risk that cannot be diversified away. Nanosphere Health holds a performance score of 9 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -0.13, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Nanosphere Health are expected to decrease at a much lower rate. During the bear market, Nanosphere Health is likely to outperform the market. Use Nanosphere Health information ratio and kurtosis , to analyze future returns on Nanosphere Health.
Auto-correlation | -0.27 |
Weak reverse predictability
Nanosphere Health Sciences has weak reverse predictability. Overlapping area represents the amount of predictability between Nanosphere Health time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nanosphere Health price movement. The serial correlation of -0.27 indicates that nearly 27.0% of current Nanosphere Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.27 | |
| Spearman Rank Test | 0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Nanosphere Health Sciences reported net income of (356,270). This is 100.1% lower than that of the Healthcare sector and 100.51% lower than that of the Biotechnology industry. The net income for all United States stocks is 100.06% higher than that of the company.
Nanosphere Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nanosphere Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nanosphere Health could also be used in its relative valuation, which is a method of valuing Nanosphere Health by comparing valuation metrics of similar companies.Nanosphere Health is currently under evaluation in net income category among its peers.
Nanosphere Fundamentals
| Return On Asset | -1.37 | |||
| Current Valuation | 298.63 K | |||
| Shares Outstanding | 10.28 M | |||
| Shares Owned By Insiders | 15.20 % | |||
| Price To Book | 3.84 X | |||
| Price To Sales | 4.93 X | |||
| Gross Profit | 218.03 K | |||
| EBITDA | (386 K) | |||
| Net Income | (356.27 K) | |||
| Cash And Equivalents | 88.45 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 44.7 K | |||
| Debt To Equity | 0.41 % | |||
| Current Ratio | 0.07 X | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | (64.68 K) | |||
| Earnings Per Share | 0.04 X | |||
| Beta | 0.12 | |||
| Market Capitalization | 267.38 K | |||
| Total Asset | 132.51 K | |||
| Z Score | -3.6 | |||
| Net Asset | 132.51 K |
About Nanosphere Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nanosphere Health Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanosphere Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanosphere Health Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Nanosphere Pink Sheet
Nanosphere Health financial ratios help investors to determine whether Nanosphere Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanosphere with respect to the benefits of owning Nanosphere Health security.